Dexamethasone and methylprednisolone do not inhibit neuritic outgrowth while inhibiting outgrowth of fibroblasts from spiral ganglion explants

References

• Clark GM, Shute SA, Shepherd RK, Carter TD. Cochlear implantation: osteoneogenesis, electrode-tissue impedance, and residual hearing. Ann Otol Rhinol Laryngol 1995; 166 (Suppl): 40–2
   Google Scholar
• Tykocinski M, Cohen LT, Pyman BC, Roland T, Jr, Treaba C, Palamara J, et al. Comparison of electrode position in the human cochlea using various perimodular electrode arrays. Am J Otol 2000; 21: 205–11
   PubMedGoogle Scholar
• Brors D, Aletsee C, Schwager K, Mlynski R, Hansen S, Schafers M, et al. Interaction of spiral ganglion neuron processes with alloplastic materials in vitro. Hear Res 2002; 167: 110–21
   PubMed Web of Science ®Google Scholar
• Hartnick CJ, Staecker H, Malgrange B, Lefebvre PP, Liu W, Moonen G, et al. Neurotrophic effects of BDNF and CNTF, alone and in combination, on postnatal day 5 rat acoustic ganglion neurons. J Neurobiol 1996; 30: 246–54
   PubMedGoogle Scholar
• Staecker H, Kopke RD, Malgrange B, Lefebvre PP, Van De Water TR. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996; 7: 889–94
   PubMed Web of Science ®Google Scholar
• Henson A, Slattery WH III, Luxford WM, Mills DM. Cochlear implant performance after reimplantation. Am J Otol 1999; 20: 56–64
   PubMedGoogle Scholar
• Clark GM, Shepherd RK, Franz BK, Dowell RC, Tong YC, Blamey PJ, et al. The histopathology of the human temporal bone and auditory central nervous system following cochlear implantation in a patient. Correlation with psychophysics and speech perception results. Acta Otolaryngol Suppl 1988; 448: 1–65
   PubMedGoogle Scholar
• Leake-Jones PA, Rebscher SJ. Cochlear pathology with chronically implanted scala tympani electrodes. Ann N Y Acad Sci 1983; 405: 203–23
   PubMedGoogle Scholar
• Namba M, Asano K, Kanai K, Kyo Y, Watanabe S, Hisamitsu T, et al. Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro. Acta Otolaryngol (Stockh) 2004; 124: 964–9
   PubMed Web of Science ®Google Scholar
• Vento G, Matassa PG, Ameglio F, Capoluongo E, Tortorolo L, Romagnoli C, et al. Effects of early dexamethasone therapy on pulmonary fibrogenic mediators and respiratory mechanics in preterm infants. European Cytokine Network 2002; 13: 207–14
   PubMedGoogle Scholar
• Tahera Y, Meltser I, Johansson P, Canlon B. Restraint stress modulates glucocorticoid receptors and nuclear factor kappa B in the cochlea. Neuroreport 2006; 17: 879–82
   PubMedGoogle Scholar
• Tahera Y, Meltser I, Johansson P, Salman H, Canlon B. Sound conditioning protects hearing by activating the hypothalamic-pituitary-adrenal axis. Neurobiol Dis 2007; 25: 189–97
   PubMedGoogle Scholar
• Himeno C, Komeda M, Izumikawa M, Takemura K, Yagi M, Weiping Y, et al. Intra-cochlea administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 2002; 167: 61–70
   PubMed Web of Science ®Google Scholar
• Taremura K, Komeda M, Yagi M, Himeno C, Izumikawa M, Doi T, et al. Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in the guinea pig. Hear Res 2004; 196: 56–68
   Google Scholar
• Tabuchi K, Oikawa K, Murasshita H, Hoshino T, Tsuji S, Hara A. Protective effect of glucocorticoids on ischemia-reperfusion injury to outer hair cells. Laryngoscope 2006; 116: 627–9
   PubMed Web of Science ®Google Scholar
• Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, Van De Water TR. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma. Otol Neurotol 2007 ( in press).
   PubMedGoogle Scholar
• Parnes LS, Sun A-H, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999; 109(Suppl 91)1–17
   PubMedGoogle Scholar
• Terunuma T, Kawauchi S, Kajihara M, Takahashi S, Hara A. Effect of acoustic stress on glucocorticoid receptor mRNA in the cochlea of the guinea pig. Brain Res Mol Brain Res 2003; 120: 65–72
   PubMedGoogle Scholar
• Mori T, Fujimura K, Yoshida M, Suzuki H. Effects of glucocorticoid receptor antagonist on CAPs threshold shift due to short-term sound exposure in guinea pigs. Auris Nasus Larynx 2004; 31: 3959
   Google Scholar
• De Ceulaer G, Johnson S, Yuperman M, Daemers K, Officiers FE, O'Donoghue GM, et al. Long-term evaluation of intracochlear steroid deposition on electrode impedance in cochlear implant patients. Otol Neurotol 2003; 24: 769–74
   PubMed Web of Science ®Google Scholar
• Oddera S, Cagnoni F, Mangraviti S, Giron-Michel J, Popova O, Canonic GW. Effect of triamcinolone acetonide on adult human lung fibroblasts: decrease in proliferation, surface molecule expression and mediator release. Int Arch Allergy Immunol 2002; 129: 152–9
   PubMed Web of Science ®Google Scholar
• Zou J, Curtis LM, Yao X, ten Cate WJ, Bagger-Sjöbäck D, Hultcrantz M, et al. Glucorticoid receptor expression in the postnatal rat cochlea. Hear Res 1995; 87: 220–7
   PubMedGoogle Scholar
• Hasson AC, Sommer WH, Metsis M, Stromberg I, Agnati LF, Fuxe K. Corticosterone actions on the hippocampus brain-derived neurotrophic factor expression are mediated by exon IV promoter. J Neuroendocrinology 2006; 18: 104–14
   PubMedGoogle Scholar
• Nicholas A, Munhoz CD, Ferguson D, Campbell L, Sapolsky R. Enhancing cognition after stress with gene therapy. J Neurosci 2006; 26: 11637–43
   PubMed Web of Science ®Google Scholar
• Leonelli E, Ballabio M, Consoli A, Roglio I, Magnaghi V, Melcangi RC. Neuroactive steroids: a therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events. J Mol Neurosci 2006; 28: 65–76
   PubMedGoogle Scholar